Physician profile
Gregory J Hale
NPI 1275503104
$905.73
in general payments reported to CMS, 2019-2025
15 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.07 · 2020: $98.71 · 2021: $247 · 2022: $57.08 · 2023: $179 · 2024: $93.29 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $207.11 | 2021-2025 | Selectsecure |
| Novo Nordisk INC | $173.70 | 2019-2022 | |
| Outset Medical INC | $119.35 | 2023 | |
| Abbott Laboratories | $87.95 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $86.44 | 2023-2024 | Gemtesa |
| Boston Scientific Corporation | $47.58 | 2024 | Wavewriter Alpha Prime 16 |
| Grt US Holding, INC. | $30.64 | 2022 | |
| Genzyme Corporation | $29.89 | 2020-2021 | |
| Amgen INC. | $27.80 | 2020-2021 | |
| Medtronic Minimed, INC. | $24.96 | 2019 | |
| Mallinckrodt Hospital Products INC. | $19.00 | 2023 | Acthar |
| Janssen Biotech, INC. | $14.38 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.34 | 2020 | |
| Chiesi USA, INC. | $11.37 | 2020 | |
| Daiichi Sankyo INC. | $11.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Hale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.